Cybin to participate in the jefferies london healthcare conference and upcoming investor events

Toronto--(business wire)--cybin inc. (neo:cybn) (nyse american:cybn) (“cybin” or the “company”), a biopharmaceutical company focused on progressing psychedelics to therapeutics®, is pleased to announce its participation in the following upcoming investor events: jefferies london healthcare conference, november 15-17, 2022 doug drysdale, cybin's chief executive officer, will present on november 15, 2022 at 8:00 a.m.
CYBN Ratings Summary
CYBN Quant Ranking